The Treatment With Nucleoside Analogues in Combination With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion: a Phase I/II, Single-blind, Randomized, GM-CSF-controlled Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Granulocyte macrophage colony stimulating factor (Primary) ; Hepatitis B immune globulin (Primary) ; Hepatitis B vaccine (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications Hepatitis B
- Focus Biomarker; Therapeutic Use
- 24 Jul 2013 Biomarkers information updated
- 09 Jul 2013 New trial record